Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development
23/05/2023 07:34
May 23 (Reuters) - Pharnext SA PHARN.PA :
* PHARNEXT REPORTS SIGNIFICANT PROGRESS IN SEARCH FOR
PHARMACEUTICAL PARTNERS TO VALUE ITS ASSETS AND FINANCE ITS
DEVELOPMENT
* PHARNEXT WILL COMMUNICATE REGULARLY ON ADVANCEMENT OF ITS
BUSINESS DEVELOPMENT PROCESS FOR PXT3003 IN CMT1A
Source text for Eikon: ID:nACT80083
Further company coverage: PHARN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Pharnext SCA
See all newsBrief: Pharnext Progresses On Charcot-Marie-Tooth Disease Study
Brief: Pharnext Reports Topline Results From Pivotal Phase III Clinical Trial Of PXT3003 In Charcot-Marie-Tooth Disease Type 1A
Brief: Pharnext Receives Offer Valuing Its Drug Candidate For Charcotmarie-Tooth Disease At Over Eur 500 Mln
Brief: Pharnext Appoints Dr Gilbert Wagener As Chief Medical Officer
Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development